EA200400061A1 - Фармацевтический состав с замаскированным вкусом и способ его получения - Google Patents

Фармацевтический состав с замаскированным вкусом и способ его получения

Info

Publication number
EA200400061A1
EA200400061A1 EA200400061A EA200400061A EA200400061A1 EA 200400061 A1 EA200400061 A1 EA 200400061A1 EA 200400061 A EA200400061 A EA 200400061A EA 200400061 A EA200400061 A EA 200400061A EA 200400061 A1 EA200400061 A1 EA 200400061A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
taste
preparation
well
masked taste
Prior art date
Application number
EA200400061A
Other languages
English (en)
Other versions
EA006016B1 (ru
Inventor
Филипп Бекур
Жозиан Шовен
Детлев Швабе
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200400061A1 publication Critical patent/EA200400061A1/ru
Publication of EA006016B1 publication Critical patent/EA006016B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение касается фармацевтического состава в форме порошка, предназначенного для перорального введения в виде водной суспензии, имеющего замаскированный вкус, содержащего, по меньшей мере, целлюлозный полимер, метакриловый полимер и действующее начало, гомогенно распределенное в молекулярном состоянии в тонко измельченной матрице, а также щелочной агент и адсорбент, способа его получения, а также способа маскировки вкуса фармацевтических продуктов.Отчет о международном поиске был опубликован 2003.03.13.
EA200400061A 2001-06-21 2002-06-21 Фармацевтический состав с замаскированным вкусом и способ его получения EA006016B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
EA200400061A1 true EA200400061A1 (ru) 2004-06-24
EA006016B1 EA006016B1 (ru) 2005-08-25

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400061A EA006016B1 (ru) 2001-06-21 2002-06-21 Фармацевтический состав с замаскированным вкусом и способ его получения

Country Status (42)

Country Link
US (2) US7138138B2 (ru)
EP (1) EP1401397B1 (ru)
JP (1) JP4880871B2 (ru)
CN (1) CN1239149C (ru)
AP (1) AP1595A (ru)
AR (1) AR036096A1 (ru)
AT (1) ATE290366T1 (ru)
AU (1) AU2002329311B2 (ru)
BG (1) BG66314B1 (ru)
BR (1) BRPI0208998A2 (ru)
CA (1) CA2452239C (ru)
CO (1) CO5540278A2 (ru)
CZ (1) CZ299947B6 (ru)
DE (1) DE60203178T2 (ru)
EA (1) EA006016B1 (ru)
EC (1) ECSP034915A (ru)
ES (1) ES2236574T3 (ru)
FR (1) FR2826274B1 (ru)
GT (2) GT200200115A (ru)
HK (1) HK1067558A1 (ru)
HR (1) HRP20031067B1 (ru)
HU (1) HUP0400799A3 (ru)
IL (2) IL159404A0 (ru)
JO (1) JO2325B1 (ru)
MA (1) MA27042A1 (ru)
MX (1) MXPA03011756A (ru)
MY (1) MY134340A (ru)
NO (1) NO332258B1 (ru)
NZ (1) NZ530042A (ru)
OA (1) OA12635A (ru)
PA (1) PA8548301A1 (ru)
PE (1) PE20030201A1 (ru)
PL (1) PL202090B1 (ru)
PT (1) PT1401397E (ru)
SK (1) SK285865B6 (ru)
SV (1) SV2003001098A (ru)
TN (1) TNSN03141A1 (ru)
TW (1) TWI228049B (ru)
UA (1) UA77960C2 (ru)
UY (1) UY27341A1 (ru)
WO (1) WO2003000225A2 (ru)
ZA (1) ZA200309479B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
EP1978936B1 (de) * 2006-02-03 2013-07-10 Evonik Röhm GmbH Pharmazeutische Zusammensetzungen, enthaltend Mischungen aus Polymeren und in Wasser schlecht löslichen Wirkstoffen
US20100226979A1 (en) * 2006-03-21 2010-09-09 Jubilant Organosys Limited Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
EP2379636B1 (en) 2008-12-16 2016-11-23 Carlsberg A/S Coating of hydroxylated surfaces by gas phase grafting
IN2014DN08939A (ru) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
WO2016022658A1 (en) * 2014-08-05 2016-02-11 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
AU9182498A (en) * 1997-10-03 1999-04-27 Elan Corporation, Plc Taste masked formulations
IN191239B (ru) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
ES2313975T3 (es) * 2000-08-22 2009-03-16 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.

Also Published As

Publication number Publication date
JP4880871B2 (ja) 2012-02-22
IL159404A0 (en) 2004-06-01
HK1067558A1 (en) 2005-04-15
CA2452239A1 (fr) 2003-01-03
OA12635A (fr) 2006-06-15
WO2003000225A3 (fr) 2003-03-13
CZ299947B6 (cs) 2009-01-07
TWI228049B (en) 2005-02-21
ECSP034915A (es) 2004-02-26
PL366803A1 (en) 2005-02-07
BRPI0208998A2 (pt) 2017-06-06
NO332258B1 (no) 2012-08-13
SK15922003A3 (sk) 2004-05-04
MY134340A (en) 2007-12-31
ATE290366T1 (de) 2005-03-15
SK285865B6 (sk) 2007-10-04
BG66314B1 (bg) 2013-04-30
EP1401397B1 (fr) 2005-03-09
HRP20031067B1 (en) 2011-10-31
EA006016B1 (ru) 2005-08-25
GT200200115A (es) 2003-02-27
NO20035581D0 (no) 2003-12-15
US7138138B2 (en) 2006-11-21
HUP0400799A3 (en) 2012-08-28
UY27341A1 (es) 2003-01-31
EP1401397A2 (fr) 2004-03-31
CA2452239C (fr) 2011-07-19
DE60203178D1 (de) 2005-04-14
IL159404A (en) 2007-08-19
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
BG108458A (bg) 2005-02-28
CO5540278A2 (es) 2005-07-29
DE60203178T2 (de) 2006-01-26
HUP0400799A2 (hu) 2004-08-30
PT1401397E (pt) 2005-05-31
AP2003002927A0 (en) 2003-12-31
ES2236574T3 (es) 2005-07-16
PE20030201A1 (es) 2003-03-12
AP1595A (en) 2006-04-12
JO2325B1 (en) 2006-06-28
JP2004534810A (ja) 2004-11-18
NZ530042A (en) 2005-09-30
AU2002329311B2 (en) 2007-02-01
MXPA03011756A (es) 2004-07-01
TNSN03141A1 (fr) 2005-12-23
HRP20031067A2 (en) 2004-04-30
MA27042A1 (fr) 2004-12-20
CN1239149C (zh) 2006-02-01
PA8548301A1 (es) 2003-09-05
GT200200115AA (es) 2005-01-12
WO2003000225A2 (fr) 2003-01-03
US20070014857A1 (en) 2007-01-18
CZ20033441A3 (en) 2004-03-17
CN1529585A (zh) 2004-09-15
UA77960C2 (en) 2007-02-15
US20040142029A1 (en) 2004-07-22
FR2826274A1 (fr) 2002-12-27
AR036096A1 (es) 2004-08-11
FR2826274B1 (fr) 2003-09-26
SV2003001098A (es) 2003-03-18

Similar Documents

Publication Publication Date Title
EA200400061A1 (ru) Фармацевтический состав с замаскированным вкусом и способ его получения
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
WO2002101412A3 (en) Spray freeze-dried compositions
EA200200571A1 (ru) Новая композиция и ее применение
BR0211028A (pt) Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
BR0307893A (pt) Formulação oftálmica com sistema de goma
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
BR0111126A (pt) Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
HUP0401569A2 (hu) Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
HUP0300896A3 (en) Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them
DK1167354T3 (da) Racemisk huperzin A
KR940005282A (ko) 안토시아노사이드를 함유하는 경구용 약제학적 조성물
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
CA2390029A1 (en) Suspension comprising oxcarbazepine
ATE315395T1 (de) Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten
EA200200383A1 (ru) Содержащая циклезонид водная фармацевтическая композиция
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
NO20055016L (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
SI0913396T1 (en) Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU